Reta~trutide
Reta~trutide
Other recommendations
Quantité
Commande minimum de: 2 boxsLivraison
Le fournisseur expédiera dans 3–10 jours après confirmation du paiement.
Les marchandises seront expédiées depuis le port de United Kingdom, China
L'expédition est proposée selon les conditions FOB — le fournisseur couvre les frais jusqu'au port de destination.
Paiement : Western Union
Échantillon disponible · $300.00/échantillon
Euromart Suppliers protection de commande
Chaque paiement que vous effectuez est sécurisé avec un cryptage SSL strict et des protocoles de protection des données PCI DSS
Effectuez des retours locaux gratuits pour les défauts sur les achats éligibles
Réclamez un remboursement si votre commande n'est pas expédiée, est manquante ou arrive avec des problèmes de produit
Meet your supplier
Distributor / Wholesaler • 3 yr • 
UNITED KINGDOM
56%
On-time delivery rate
≤24h
Response Time
75
Employee Size
$500K
Annual Revenue
588
Products Sold
Location
Belfast, United Kingdom
Other recommendations
KEY FEATURES
Therapeutic Class: Investigational peptide therapy
Mechanism of Action: Triple receptor agonist (GIP, GLP‑1, glucagon)
Primary Uses (Investigational): Obesity management, metabolic regulation, type 2 diabetes (under study)
Clinical Benefits (Trial Data):
Up to 24–25% body weight reduction in <1 year
Improved glucose metabolism and insulin sensitivity
Appetite suppression and increased energy expenditure
Status: Not FDA‑approved; currently in Phase II/III clinical trials
TECHNICAL SPECIFICATIONS
Molecular Type: Synthetic peptide (LY‑3437943)
Administration Route: Subcutaneous injection (once weekly)
Formulation: Prefilled injection pens (trial use)
Stability & Storage: Refrigerated until use; stability data under investigation
Safety Profile (Investigational):
GI side effects (nausea, diarrhea)
Risks under study: bone health, kidney complications, rapid weight loss
Regulatory Identifiers: Not yet assigned ATC code or HS classification (pending approval)
AVAILABLE CONFIGURATIONS
Format & Delivery:
Prefilled injection pens (trial formulations)
Bulk API (research supply only)
Concentration & Dosing:
Investigational fixed strengths (dose escalation in trials)
No commercial dosing yet established
Packaging & Labeling:
Clinical trial packaging only
Future potential: finished product packaging, private labeling (post‑approval)
Ratings & Reviews
From Other Suppliers
Ozempic 2 Pens 0.25mg + 0.5mg Wholesale & Retail in Europe, UK, USA, Asia
MOQ: 8 pieces71 sold
USOzempic Injection – Semaglutide Injection 025mg 0.5mg 1mg, 1 Pen
MOQ: 10 pieces31 sold
USOzempic Pens 0.25mg Wholesale & Retail in Europe, UK, USA, Asia
MOQ: 6 pieces39 sold
US
GB
